These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
874 related items for PubMed ID: 26191245
21. Is cerebrospinal fluid obtained for diagnostic purpose a good material for biomarker studies in amyotrophic lateral sclerosis? Chełstowska B, Kuźma-Kozakiewicz M. Biomarkers; 2014 Nov; 19(7):571-7. PubMed ID: 25133306 [Abstract] [Full Text] [Related]
22. The 10-metre gait speed as a functional biomarker in amyotrophic lateral sclerosis. Inam S, Vucic S, Brodaty NE, Zoing MC, Kiernan MC. Amyotroph Lateral Scler; 2010 Dec; 11(6):558-61. PubMed ID: 20515425 [Abstract] [Full Text] [Related]
23. Increased TDP-43 protein in cerebrospinal fluid of patients with amyotrophic lateral sclerosis. Kasai T, Tokuda T, Ishigami N, Sasayama H, Foulds P, Mitchell DJ, Mann DM, Allsop D, Nakagawa M. Acta Neuropathol; 2009 Jan; 117(1):55-62. PubMed ID: 18989684 [Abstract] [Full Text] [Related]
24. Association between nutritional status and disease severity using the amyotrophic lateral sclerosis (ALS) functional rating scale in ALS patients. Park Y, Park J, Kim Y, Baek H, Kim SH. Nutrition; 2015 Jan; 31(11-12):1362-7. PubMed ID: 26429656 [Abstract] [Full Text] [Related]
25. Cerebrospinal fluid MFG-E8 as a promising biomarker of amyotrophic lateral sclerosis. Yang B, Wu Y, Wang Y, Yang H, Du B, Di W, Xu X, Shi X. Neurol Sci; 2020 Oct; 41(10):2915-2920. PubMed ID: 32338335 [Abstract] [Full Text] [Related]
26. Cerebrospinal Fluid Neurofilaments May Discriminate Upper Motor Neuron Syndromes: A Pilot Study. Zucchi E, Bedin R, Fasano A, Fini N, Gessani A, Vinceti M, Mandrioli J. Neurodegener Dis; 2018 Oct; 18(5-6):255-261. PubMed ID: 30428468 [Abstract] [Full Text] [Related]
27. The increase in CSF total protein and immunoglobulins in Chinese patients with sporadic amyotrophic lateral sclerosis: A retrospective study. Zhao X, Yang F, Wang H, Cui F, Li M, Sun B, Li Y, Sun Q, He Z, Li Y, Huang X. J Neurol Sci; 2020 Jul 15; 414():116840. PubMed ID: 32388062 [Abstract] [Full Text] [Related]
28. Identification of potential CSF biomarkers in ALS. Pasinetti GM, Ungar LH, Lange DJ, Yemul S, Deng H, Yuan X, Brown RH, Cudkowicz ME, Newhall K, Peskind E, Marcus S, Ho L. Neurology; 2006 Apr 25; 66(8):1218-22. PubMed ID: 16481598 [Abstract] [Full Text] [Related]
29. [Revised amyotrophic lateral sclerosis functional rating scale at time of diagnosis predicts survival time in amyotrophic lateral sclerosis]. Liu XX, Fan DS, Zhang J, Zhang S, Zheng JY. Zhonghua Yi Xue Za Zhi; 2009 Sep 22; 89(35):2472-5. PubMed ID: 20137433 [Abstract] [Full Text] [Related]
33. Serum asymmetric dimethylarginine level correlates with the progression and prognosis of amyotrophic lateral sclerosis. Ikenaka K, Maeda Y, Hotta Y, Nagano S, Yamada S, Ito D, Torii R, Kakuda K, Tatebe H, Atsuta N, Aguirre C, Kimura Y, Baba K, Tokuda T, Katsuno M, Kimura K, Sobue G, Mochizuki H. Eur J Neurol; 2022 May 22; 29(5):1410-1416. PubMed ID: 35128793 [Abstract] [Full Text] [Related]
35. Elimination Rate of Serum Lactate is Correlated with Amyotrophic Lateral Sclerosis Progression. Zhang YJ, Fan DS. Chin Med J (Engl); 2016 Jan 05; 129(1):28-32. PubMed ID: 26712429 [Abstract] [Full Text] [Related]
36. Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value. Noto Y, Shibuya K, Sato Y, Kanai K, Misawa S, Sawai S, Mori M, Uchiyama T, Isose S, Nasu S, Sekiguchi Y, Fujimaki Y, Kasai T, Tokuda T, Nakagawa M, Kuwabara S. Amyotroph Lateral Scler; 2011 Mar 05; 12(2):140-3. PubMed ID: 21126161 [Abstract] [Full Text] [Related]